ACTC sure has some singular positives and that's why we both are invested in it.
Imo, your bullishness,e.g., on potential animal clinical positives, that might be a decade away from potentially producing revenue and even 20/40 on ONE patient today , are just not the stuff that excites wall street and investors for more than a few hours.
Things like financial stability and revenue and more clinical data, are the stuff of excitement, I would suggest.
Yes, I like you, am entitled to my opinions and assessment, which I believe to be more in 'touch' with wall street and serious investor reality.
If my assessment were wrong, yours might prevail and we would be much higher in share price than we are.
We just can't talk ACTC to a higher price on our hopefulness or excitement about things in the pipeline. You know that, I hope.
The facts and dynamics currently effecting us, are just still 'weak', even given all our progress and promise, imo.
Yes, I still love the company and hope some of us can be around to realize the 'fruits' of our longtime investment in the near future.I would welcome a post that suggests what developments this year could help our share price and investment in this promising company.
